Comparison of the Complications in Multiple Myeloma Patients Who Received Autologous Stem Cell Transplantation Between in HEPA-filtered Room and Non-HEPA-filtered Room
Not yet recruiting
- Conditions
- Multiple Myeloma
- Registration Number
- NCT06286241
- Lead Sponsor
- Siriraj Hospital
- Brief Summary
The goal of this observational study is to comparison of the complications in multiple myeloma patients who received autologous stem cell transplantation between in HEPA-filtered room and non-HEPA-filtered room. The main questions it aims to answer are:
* The incidence of febrile neutropenia, infection, and duration of hospital stay
* 2-year progression free survival Participants will be collected the data of baseline diagnosis, treatment, treatment results and complications during admission and follow-up visits from hospital medical record.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 344
Inclusion Criteria
- aged 18 - 65 years old
- Patients with multiple myeloma undergoing treatment with autologous stem cell transplantation and having a Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) score less than or equal to 2
- Patients must provide signed consent to participate in the research if they undergo ASCT after the study has been approved.
- If patients undergo ASCT before the study approval, retrospective data will be collected.
Exclusion Criteria
- Patients with concomitant other types of cancer
- Patients who refuse to participate in the study.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method febrile neutropenia during admission incidence of febrile neutropenia
Infection during admission incidence of Infection
duration of admission during admission duration of admission
progression free survival 2 years duration of survival
- Secondary Outcome Measures
Name Time Method